NASDAQ$VIR

Vir Biotechnology Inc · Q3 2019 earnings

Q3 2019 earnings · · Investor relations

Headline financials

Total Revenue

$1.4M

Previous: $114K+1130.7%
EPS (adj)

-$4.60

Previous: -$0.35-1232.5%
R&D expenses

$39.9M

No prior period
Capital Expenditures

-$7.39M

No prior period
Free Cash Flow

-$55.7M

No prior period
Net Income

-$48.3M

Previous: -$33.5M-44.4%
Operating Income

-$47.7M

Previous: -$34.3M-38.8%
Gross Profit

$1.4M

Previous: -$29.7M+104.7%
Cash & Equivalents

$93.7M

No prior period
Total Assets

$423M

No prior period
Stock-Based Comp

$2.19M

No prior period

Revenue & EPS history

Vir · Revenue · Quarterly

$1.4M

Q3 2019+1,130.7%vs Q3 2018
Beat estimate in 7 of 10 quarters(70%)
ActualEstimate

Revenue by segment

Vir · $1.17M total across 1 segment · Q3 2019

  • Grant revenue
    $1.17M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports

Historical avg

+2.0%

Avg return

Earnings day

-0.4%

Avg return

5 days after

-1.3%

Avg return

30 days after

43%

12 / 28 earnings

Positive

+27.7%

Q4 2025

Best reaction

-15.1%

Q3 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.8%-7.2%-13.7%
Q4 2025+27.7%+22.3%+20.6%
Q3 2025-5.6%-8.9%+8.3%
Q1 2025-3.4%-16.2%-2.9%
Q4 2024-11.8%-10.9%-27.2%
Q3 2024+21.8%+26.8%+4.7%
Q2 2024-9.4%-15.4%-18.7%
Q1 2024+18.9%+13.6%+17.5%
Q4 2023+14.0%+13.1%-0.6%
Q3 2023+12.5%+8.3%+24.4%
Q2 2023-3.0%-4.8%-10.9%
Q1 2023-3.5%-4.5%+7.5%
Q4 2022-14.8%-15.6%-16.7%
Q3 2022+15.0%+20.3%+23.7%
Q2 2022+2.0%-4.9%-25.9%
Q1 2022-3.1%-1.4%+12.5%
Q4 2021+0.1%-13.7%-21.5%
Q3 2021-15.1%-11.7%+20.4%
Q2 2021+3.3%+10.5%+32.0%
Q1 2021-1.0%-8.5%+3.5%
Q4 2020-4.2%-11.7%-21.2%
Q3 2020+8.2%+5.8%+26.0%
Q2 2020-0.6%-0.9%-46.8%
Q2 2019-0.6%-0.9%-46.8%
Q1 2020-1.9%-3.1%+7.2%
Q1 2019-1.9%-3.1%+7.2%
Q4 2019+11.5%+11.4%+6.0%
Q3 2019-3.0%-0.5%-3.7%
Q4 2018
Q3 2018
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro